CPT2_HUMAN - dbPTM
CPT2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CPT2_HUMAN
UniProt AC P23786
Protein Name Carnitine O-palmitoyltransferase 2, mitochondrial
Gene Name CPT2
Organism Homo sapiens (Human).
Sequence Length 658
Subcellular Localization Mitochondrion inner membrane
Peripheral membrane protein
Matrix side.
Protein Description
Protein Sequence MVPRLLLRAWPRGPAVGPGAPSRPLSAGSGPGQYLQRSIVPTMHYQDSLPRLPIPKLEDTIRRYLSAQKPLLNDGQFRKTEQFCKSFENGIGKELHEQLVALDKQNKHTSYISGPWFDMYLSARDSVVLNFNPFMAFNPDPKSEYNDQLTRATNMTVSAIRFLKTLRAGLLEPEVFHLNPAKSDTITFKRLIRFVPSSLSWYGAYLVNAYPLDMSQYFRLFNSTRLPKPSRDELFTDDKARHLLVLRKGNFYIFDVLDQDGNIVSPSEIQAHLKYILSDSSPAPEFPLAYLTSENRDIWAELRQKLMSSGNEESLRKVDSAVFCLCLDDFPIKDLVHLSHNMLHGDGTNRWFDKSFNLIIAKDGSTAVHFEHSWGDGVAVLRFFNEVFKDSTQTPAVTPQSQPATTDSTVTVQKLNFELTDALKTGITAAKEKFDATMKTLTIDCVQFQRGGKEFLKKQKLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETIRPASVYTKRCSEAFVREPSRHSAGELQQMMVECSKYHGQLTKEAAMGQGFDRHLFALRHLAAAKGIILPELYLDPAYGQINHNVLSTSTLSSPAVNLGGFAPVVSDGFGVGYAVHDNWIGCNVSSYPGRNAREFLQCVEKALEDMFDALEGKSIKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
38PhosphorylationPGQYLQRSIVPTMHY
CCHHHHHHCCCCCCC
18.2520068231
42PhosphorylationLQRSIVPTMHYQDSL
HHHHCCCCCCCCCCC
12.9920068231
45PhosphorylationSIVPTMHYQDSLPRL
HCCCCCCCCCCCCCC
11.8220068231
48PhosphorylationPTMHYQDSLPRLPIP
CCCCCCCCCCCCCCC
25.4220068231
51MethylationHYQDSLPRLPIPKLE
CCCCCCCCCCCCCHH
59.39-
60PhosphorylationPIPKLEDTIRRYLSA
CCCCHHHHHHHHHHH
13.6520068231
69AcetylationRRYLSAQKPLLNDGQ
HHHHHHCCCCCCCCC
37.0320167786
69SuccinylationRRYLSAQKPLLNDGQ
HHHHHHCCCCCCCCC
37.03-
69UbiquitinationRRYLSAQKPLLNDGQ
HHHHHHCCCCCCCCC
37.03-
69SuccinylationRRYLSAQKPLLNDGQ
HHHHHHCCCCCCCCC
37.0323954790
79AcetylationLNDGQFRKTEQFCKS
CCCCCCHHHHHHHHH
58.67-
79SuccinylationLNDGQFRKTEQFCKS
CCCCCCHHHHHHHHH
58.6727452117
85SuccinylationRKTEQFCKSFENGIG
HHHHHHHHHHHCCCC
60.51-
85SuccinylationRKTEQFCKSFENGIG
HHHHHHHHHHHCCCC
60.51-
85AcetylationRKTEQFCKSFENGIG
HHHHHHHHHHHCCCC
60.5125038526
104MalonylationEQLVALDKQNKHTSY
HHHHHHHHCCCCCCC
57.5326320211
126PhosphorylationMYLSARDSVVLNFNP
EEEECCCEEEEECCC
14.4720068231
153PhosphorylationNDQLTRATNMTVSAI
HHHHHHHHHCHHHHH
23.4120860994
156PhosphorylationLTRATNMTVSAIRFL
HHHHHHCHHHHHHHH
17.2424400094
158PhosphorylationRATNMTVSAIRFLKT
HHHHCHHHHHHHHHH
14.6020860994
165PhosphorylationSAIRFLKTLRAGLLE
HHHHHHHHHHHCCCC
24.5122210691
182UbiquitinationVFHLNPAKSDTITFK
EEECCCCCCCCEEHH
50.55-
187PhosphorylationPAKSDTITFKRLIRF
CCCCCCEEHHHHHHH
25.7922210691
1892-HydroxyisobutyrylationKSDTITFKRLIRFVP
CCCCEEHHHHHHHCC
37.33-
197PhosphorylationRLIRFVPSSLSWYGA
HHHHHCCCCCCHHHH
38.3120068231
198PhosphorylationLIRFVPSSLSWYGAY
HHHHCCCCCCHHHHH
21.9820068231
200PhosphorylationRFVPSSLSWYGAYLV
HHCCCCCCHHHHHHH
21.8720068231
202PhosphorylationVPSSLSWYGAYLVNA
CCCCCCHHHHHHHHC
6.6220068231
205PhosphorylationSLSWYGAYLVNAYPL
CCCHHHHHHHHCEEC
13.5620068231
210PhosphorylationGAYLVNAYPLDMSQY
HHHHHHCEECCHHHH
10.1020068231
215PhosphorylationNAYPLDMSQYFRLFN
HCEECCHHHHHHHHC
22.7720068231
217PhosphorylationYPLDMSQYFRLFNST
EECCHHHHHHHHCCC
5.3720068231
223PhosphorylationQYFRLFNSTRLPKPS
HHHHHHCCCCCCCCC
13.9420068231
224PhosphorylationYFRLFNSTRLPKPSR
HHHHHCCCCCCCCCH
37.0120068231
239SuccinylationDELFTDDKARHLLVL
HHCCCCHHHHEEEEE
50.56-
239AcetylationDELFTDDKARHLLVL
HHCCCCHHHHEEEEE
50.5625038526
239SuccinylationDELFTDDKARHLLVL
HHCCCCHHHHEEEEE
50.56-
290PhosphorylationAPEFPLAYLTSENRD
CCCCCHHHHCCCCHH
20.42-
305MalonylationIWAELRQKLMSSGNE
HHHHHHHHHHHCCCH
39.4626320211
305AcetylationIWAELRQKLMSSGNE
HHHHHHHHHHHCCCH
39.4625953088
307SulfoxidationAELRQKLMSSGNEES
HHHHHHHHHCCCHHH
3.7421406390
308PhosphorylationELRQKLMSSGNEESL
HHHHHHHHCCCHHHH
45.5923403867
309PhosphorylationLRQKLMSSGNEESLR
HHHHHHHCCCHHHHH
31.5023403867
320PhosphorylationESLRKVDSAVFCLCL
HHHHHHCHHHHHEEC
29.3526074081
339PhosphorylationIKDLVHLSHNMLHGD
HHHHHHHCCCCCCCC
9.6526074081
348PhosphorylationNMLHGDGTNRWFDKS
CCCCCCCCCCCCCCC
26.7626074081
389AcetylationRFFNEVFKDSTQTPA
HHHHHHHCCCCCCCC
56.8125038526
424AcetylationFELTDALKTGITAAK
EEHHHHHHHCCHHHH
46.5625038526
424SuccinylationFELTDALKTGITAAK
EEHHHHHHHCCHHHH
46.56-
424SuccinylationFELTDALKTGITAAK
EEHHHHHHHCCHHHH
46.56-
439SuccinylationEKFDATMKTLTIDCV
HHHCCCCCEEEEEEE
35.71-
439SuccinylationEKFDATMKTLTIDCV
HHHCCCCCEEEEEEE
35.71-
453SuccinylationVQFQRGGKEFLKKQK
EEECCCCHHHHHHCC
48.3823954790
453AcetylationVQFQRGGKEFLKKQK
EEECCCCHHHHHHCC
48.3826822725
453MalonylationVQFQRGGKEFLKKQK
EEECCCCHHHHHHCC
48.3826320211
490PhosphorylationVATYESCSTAAFKHG
EEEHHHHCCCHHHCC
30.29-
491PhosphorylationATYESCSTAAFKHGR
EEHHHHCCCHHHCCC
26.74-
495AcetylationSCSTAAFKHGRTETI
HHCCCHHHCCCCCCC
40.1826051181
508PhosphorylationTIRPASVYTKRCSEA
CCCCCCCEECCCHHH
12.21-
510SuccinylationRPASVYTKRCSEAFV
CCCCCEECCCHHHHC
33.45-
510SuccinylationRPASVYTKRCSEAFV
CCCCCEECCCHHHHC
33.45-
510AcetylationRPASVYTKRCSEAFV
CCCCCEECCCHHHHC
33.4519608861
510MethylationRPASVYTKRCSEAFV
CCCCCEECCCHHHHC
33.4519608861
513PhosphorylationSVYTKRCSEAFVREP
CCEECCCHHHHCCCC
35.6723312004
537MalonylationQMMVECSKYHGQLTK
HHHHHHHHHHCCCHH
53.5826320211
537AcetylationQMMVECSKYHGQLTK
HHHHHHHHHHCCCHH
53.5819608861
544MalonylationKYHGQLTKEAAMGQG
HHHCCCHHHHHCCCC
54.6826320211
544SuccinylationKYHGQLTKEAAMGQG
HHHCCCHHHHHCCCC
54.6823954790
544SuccinylationKYHGQLTKEAAMGQG
HHHCCCHHHHHCCCC
54.68-
544AcetylationKYHGQLTKEAAMGQG
HHHCCCHHHHHCCCC
54.6823954790
554MethylationAMGQGFDRHLFALRH
HCCCCHHHHHHHHHH
26.58-
655PhosphorylationFDALEGKSIKS----
HHHHCCCCCCC----
46.2128857561
658PhosphorylationLEGKSIKS-------
HCCCCCCC-------
43.7328857561

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CPT2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CPT2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CPT2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
G6PI_YEASTPGI1physical
22493507
3HAO_YEASTBNA1physical
22493507
CCHL_HUMANHCCSphysical
26344197

Drug and Disease Associations
Kegg Disease
H00525 Disorders of fatty-acid oxidation, including: Medium-chain (MC) acyl-CoA dehydrogenase (AD) deficien
OMIM Disease
255110Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D)
600649Carnitine palmitoyltransferase 2 deficiency infantile (CPT2DI)
608836Carnitine palmitoyltransferase 2 deficiency lethal neonatal (CPT2D-LN)
614212Encephalopathy, acute, infection-induced, 4 (IIAE4)
Kegg Drug
D05442 Perhexiline maleate (USAN)
D08340 Perhexiline (INN)
DrugBank
DB00583L-Carnitine
DB01074Perhexiline
Regulatory Network of CPT2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-510 AND LYS-544, AND MASSSPECTROMETRY.

TOP